APPLICATION OF EVIDENCE-BASED MEDICINE IN THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES
Article Sidebar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Main Article Content
Abstract:
Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide, necessitating the use of the most effective and scientifically sound approaches to their diagnosis and treatment. Evidence-based medicine plays a key role in the development and implementation of clinical decisions based on the results of high-quality scientific research and international guidelines. This article examines the current principles of using evidence-based medicine in the diagnosis and treatment of cardiovascular diseases. It analyzes the potential for using clinical guidelines, instrumental and laboratory diagnostic methods, and evidence-based therapeutic strategies. It is demonstrated that the implementation of evidence-based approaches contributes to increased diagnostic accuracy, treatment effectiveness, and improved prognosis for patients with cardiovascular diseases.
Article Details
How to Cite:
References:
World Health Organization. (2023). Cardiovascular diseases (CVDs): Fact sheet. World Health Organization.
European Society of Cardiology. (2021). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42(36), 3599–3726. https://doi.org/10.1093/eurheartj/ehab368
American Heart Association. (2022). Heart disease and stroke statistics—2022 update. Circulation, 145(8), e153–e639. https://doi.org/10.1161/CIR.0000000000001052
American College of Cardiology. (2021). ACC/AHA guideline for the management of cardiovascular disease. Journal of the American College of Cardiology, 77(4), e25–e197. https://doi.org/10.1016/j.jacc.2020.11.002
Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996). Evidence based medicine: What it is and what it isn’t. BMJ, 312(7023), 71–72. https://doi.org/10.1136/bmj.312.7023.71
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., Hindricks, G., Kastrati, A., Lenzen, M. J., Prescott, E., Roffi, M., Valgimigli, M., Varenhorst, C., Vranckx, P., & Widimský, P. (2018). 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, 39(2), 119–177. https://doi.org/10.1093/eurheartj/ehx393
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., Kahan, T., Mahfoud, F., Redon, J., Ruilope, L., Zanchetti, A., & Kerins, M. (2018). 2018 ESC/ESH guidelines for the management of arterial hypertension. European Heart Journal, 39(33), 3021–3104. https://doi.org/10.1093/eurheartj/ehy339
Yusuf, S., Joseph, P., Rangarajan, S., Islam, S., Mente, A., Hystad, P., Brauer, M., Kutty, V. R., Gupta, R., Wielgosz, A., AlHabib, K. F., Dans, A., Lopez-Jaramillo, P., Avezum, A., Lanas, F., Oguz, A., Kruger, I. M., Diaz, R., & Teo, K. (2020). Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE study). The Lancet, 395(10226), 795–808. https://doi.org/10.1016/S0140-6736(19)32008-2
Braunwald, E. (2019). The war against heart failure: The Lancet lecture. The Lancet, 393(10175), 812–824. https://doi.org/10.1016/S0140-6736(18)32893-0